Department of Surgery, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan
Department of Surgery, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.
Anticancer Res. 2023 Nov;43(11):5139-5147. doi: 10.21873/anticanres.16714.
BACKGROUND/AIM: Recent studies have reported that the C-reactive protein (CRP) to albumin ratio (CAR) may be a useful prognostic biomarker in various types of cancer patients. However, the mechanism underlying this observation is unclear. The present study aimed to clarify why the CAR can predict post-esophagectomy prognosis, the relationship between pre- and postoperative CAR, and whether postoperative CAR can predict the prognosis of esophageal cancer patients.
We investigated 158 esophagectomy patients with esophageal squamous cell carcinoma. Hematological examinations were performed on postoperative days (POD) 1, 3, 5, 7, 10, and 14.
Preoperative CAR was a significant independent prognostic factor of overall survival (OS) [hazard ratio (HR)=2.247; p=0.0005], and there was a strong correlation between preoperative CAR and tumor depth. The preoperative high-CAR (pre-high-CAR) group had significantly higher CAR on all postoperative days (POD). We then divided the patients as follows: those with at least two low-CAR days on POD 5, 7, and 10 were assigned to the modified post-low-CAR (mPost-low-CAR) group, and others were assigned to the modified post-high-CAR (mPost-high-CAR) group. The 5-year OS rate was significantly higher in the mPost-low-CAR group than in the mPost-high-CAR group, which predicted a more accurate prognosis (p<0.0001, HR=2.769).
Preoperative CAR was associated with tumor depth and diameter, and patients in the pre-high-CAR group continued to have significantly higher CAR postoperatively. These factors were presumed to reflect disease prognosis. Furthermore, grouping by CAR on POD 5, 7, and 10 reflected patient prognosis more accurately than preoperative CAR.
背景/目的:最近的研究报告称,C 反应蛋白(CRP)与白蛋白比值(CAR)可能是各种类型癌症患者有用的预后生物标志物。然而,这一观察结果的机制尚不清楚。本研究旨在阐明为什么 CAR 可以预测食管癌患者术后预后,术前和术后 CAR 的关系,以及术后 CAR 是否可以预测食管癌患者的预后。
我们调查了 158 例接受食管鳞癌切除术的患者。在术后第 1、3、5、7、10 和 14 天进行血液检查。
术前 CAR 是总生存期(OS)的显著独立预后因素[风险比(HR)=2.247;p=0.0005],且术前 CAR 与肿瘤深度密切相关。术前高-CAR(pre-high-CAR)组在所有术后日(POD)的 CAR 均显著升高。然后我们将患者分为以下两组:至少有两个低-CAR 日(POD5、7 和 10)的患者归入改良后低-CAR(mPost-low-CAR)组,其他患者归入改良后高-CAR(mPost-high-CAR)组。mPost-low-CAR 组的 5 年 OS 率明显高于 mPost-high-CAR 组,提示预后更准确(p<0.0001,HR=2.769)。
术前 CAR 与肿瘤深度和直径有关,pre-high-CAR 组患者术后 CAR 持续显著升高。这些因素被认为反映了疾病的预后。此外,根据 POD5、7 和 10 的 CAR 进行分组比术前 CAR 更能准确反映患者的预后。